Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership
Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership
Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
25<br />
ANNUAL REPORT<br />
<strong>2011</strong><br />
Stockpile<br />
In <strong>2011</strong>, 60 countries received SLDs from<br />
the stockpile – 20 of which required the drugs<br />
for emergency orders. The average stockpile<br />
turnover ratio was an average of 6.3 turns –<br />
i.e. rotation every 58 days. However, the<br />
rotation varied depending on the products,<br />
with the highest turnover being capreomycin<br />
with 40.19 turns (due to long lead times<br />
for production and acute shortages during<br />
the first half of <strong>2011</strong>). The lowest rotation<br />
ratios were for ofloxacin (which is no longer<br />
recommended) and levofloxacin 500 mg<br />
(most national programmes prefer to order<br />
the 250 mg formulation).<br />
Located in Amsterdam, Netherlands, the<br />
stockpile is jointly administered by IDA and<br />
GDF. Orders are prioritized based on the date<br />
of receipt and in recognition of the importance<br />
of planning in good time to ensure that the<br />
order can be filled. GDF re-orders products<br />
when stockpile levels reach 60% consumption.<br />
The stockpile was established in 2007 with<br />
a grant of $13 686 737 from UNITAID.